Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Clinical trial NCT04217694 · COMPLETED

Trial details

NCT number: NCT04217694
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Malignant Central Nervous System Neoplasm Primary Central Nervous System Neoplasm

Start date: 2020-02-17
Primary completion: 2022-09-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.